- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 144807 intermediate dose
Total 144 results
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedWet Macular DegenerationAustria, Germany, Hungary
-
Boehringer IngelheimCompletedHealthy | AsthmaUnited Kingdom
-
Alkahest, Inc.CompletedWet Age-related Macular DegenerationHungary
-
Alkahest, Inc.CompletedWet Age-related Macular DegenerationHungary
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany, Netherlands
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedLupus NephritisSpain, United Kingdom, United States, Canada, Thailand, Germany, Italy, Japan, Serbia, Australia, Korea, Republic of, Mexico, Malaysia, Philippines, Poland, Portugal, Greece, Hong Kong, Czechia, France
-
Pharnext SACompletedCharcot-Marie-Tooth Disease | Hereditary Neuropathy With Liability to Pressure Palsies | Genetic DisordersFrance
-
Stealth BioTherapeutics Inc.CompletedMitochondrial MyopathyUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Boehringer IngelheimCompletedSchizophreniaSpain, Korea, Republic of, United Kingdom, Taiwan, United States, Austria, Italy, Germany, Poland, Japan, Canada
-
KBio IncCompleted
-
Boehringer IngelheimCompletedAlzheimer DiseaseSpain, United Kingdom, Italy, United States, Canada, Germany, Greece, Austria, Norway, France, Japan, Hungary, Poland, Finland
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Netherlands Organisation for Scientific Research; Aspen Pharma; CHU of Saint... and other collaboratorsCompletedPulmonary Embolism | Deep Venous ThrombosisNorway, Netherlands, Denmark, France, Belgium, Ireland, United States, Canada, Russian Federation, Spain
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Janssen Research & Development, LLCJanssen Research & Development, LLCActive, not recruitingX-Linked Retinitis PigmentosaUnited States, Canada, Israel, United Kingdom, Spain, Denmark, France, Belgium, Italy, Netherlands, Switzerland
-
Boehringer IngelheimCompleted
-
AbbVieBoehringer IngelheimCompletedPsoriasisUnited States, Germany, United Kingdom
-
Chiesi Farmaceutici S.p.A.Active, not recruitingIdiopathic Pulmonary FibrosisNorth Macedonia, Ukraine, United Kingdom
-
Mashhad University of Medical SciencesUnknownGraves' DiseaseIran, Islamic Republic of
-
University of IowaCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHepatitis C, ChronicFrance, Germany, Switzerland
-
BioprojetCompletedAlcohol Use DisorderFrance, Bulgaria, Russian Federation
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
The First Affiliated Hospital of Soochow UniversityUnknown
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Boehringer IngelheimCompleted
-
University Medical Center GroningenCompletedAnesthesia | Hemodynamic Instability | Interaction | Disorder of Oxygen TransportNetherlands
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
Allergy TherapeuticsCompleted
-
Maastricht University Medical CenterUnknownHematologic Neoplasms | Thrombocytopenia | Anticoagulants | Platelet Aggregation InhibitorsNetherlands, Italy, Israel, United States
-
Presidio Pharmaceuticals, Inc.Boehringer IngelheimCompletedChronic Hepatitis CUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Denmark, France, Ireland, Korea, Republic of, Portugal, United Kingdom
-
OSE ImmunotherapeuticsBoehringer IngelheimActive, not recruitingSolid Tumor, AdultFrance, Belgium
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Germany, Spain, United Kingdom
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanTerminatedNon-Hodgkin's LymphomaJapan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, China, France, Germany, India, Korea, Republic of, Mexico, Slovakia, Slovenia, Taiwan, Turkey
-
SeqirusDepartment of Health and Human ServicesRecruitingInfections | Virus Diseases | Respiratory Tract Infections | Influenza, Human | Infection ViralPhilippines, United States
-
Boehringer IngelheimCompleted